Skip to content

Variable Pressure Support Trial

International Multicenter Randomized Controlled Open Trial on Variable vs. Non-Variable Pressure Support for Weaning From Mechanical Ventilation

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01769053
Acronym
ViPS
Enrollment
130
Registered
2013-01-16
Start date
2013-01-31
Completion date
2018-01-31
Last updated
2018-07-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Lung Injury, Adult Respiratory Distress Syndrome, at Least 24 h of Controlled Mechanical Ventilation

Keywords

Acute Lung Injury, Adult Respiratory Distress Syndrome, Interactive Ventilatory Support, Positive-Pressure Respiration, Ventilator-Induced Lung Injury

Brief summary

In 2008 a new ventilation strategy termed variable Pressure Support ventilation (PSV) was introduced, which is able to increase the variability of the respiratory pattern independent from the inspiratory effort. In experimental lung injury, variable PSV was found to improve gas exchange and decrease the inspiratory effort, while reducing alveolar edema and inflammatory infiltration compared to conventional(non-variable) PSV. Importantly, variable PSV reduced peak airway pressure and respiratory system elastance in a variability dependent manner.In addition, preliminary observations suggest that variable PSV can reduce the work of breathing and improve patient comfort, but it is not known whether this new ventilatory strategy is able to speed the weaning from mechanical ventilation. Since variable PSV can reduce the mean pressure support, it may lead to a faster reduction of pressure support and, therefore, a shorter weaning period than conventional PSV. The hypothesis of this study is that variable pressure support ventilation reduces the duration of mechanical ventilation to non-variable (conventional) pressure support ventilation.

Interventions

Sponsors

Medical University of Vienna
CollaboratorOTHER
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
CollaboratorOTHER
University Hospital, Montpellier
CollaboratorOTHER
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
CollaboratorOTHER
IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy
CollaboratorOTHER
St Thomas' Hospital, London
CollaboratorOTHER
Hospital Sírio-Libânes, São Paulo, Brazil
CollaboratorUNKNOWN
Hospital Copa D'Or, Rio de Janeiro, Brazil
CollaboratorUNKNOWN
Hospital Universitari Sant Joan de Reus
CollaboratorOTHER
University of Kiel
CollaboratorOTHER
Fachkrankenhaus Coswig GmbH
CollaboratorINDUSTRY
Technische Universität Dresden
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age ≥ 18 years * Duration of controlled mechanical ventilation ≥ 24h * Availability of a Infinity V500 ventilator (ready to use) * Informed consent according to local regulations * Temperature ≤ 39 °C * Hemoglobin ≥ 6 g/dl * PaO2/FIO2 ≥ 150 mmHg with positive end-expiratory pressure (PEEP) ≤16 cmH2O * Ability to breath spontaneously

Exclusion criteria

* Participation in another interventional trial within the last four weeks before enrollment in this trial * Peripheral neurological disease associated with impairment of the respiratory pump * Muscular disease associated with impairment of the respiratory pump * Instable thorax with paradoxical chest wall movement * Planned surgery under general anesthesia within 72 hours * Difficult airway/intubation * Existing tracheotomy at ICU admission * Expected survival \< 72 hours * Home mechanical ventilation or on chronic oxygen therapy * Suspected pregnancy

Design outcomes

Primary

MeasureTime frameDescription
Weaning timeFrom time of randomization until the time of successful extubation, estimated to be up to 30 daysWeaning time defined as time from randomization to successful extubation.

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 22, 2026